These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 27699535)

  • 1. Human Papillomavirus (HPV): A Criterion for Therapeutic Decision in Squamous Cell Carcinoma of the Head and Neck?
    Vermorken JB
    Recent Results Cancer Res; 2017; 206():137-147. PubMed ID: 27699535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p16, HPV, and Cetuximab: What Is the Evidence?
    Bonner JA; Mesia R; Giralt J; Psyrri A; Keilholz U; Rosenthal DI; Beier F; Schulten J; Vermorken JB
    Oncologist; 2017 Jul; 22(7):811-822. PubMed ID: 28526718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab.
    Rosenthal DI; Harari PM; Giralt J; Bell D; Raben D; Liu J; Schulten J; Ang KK; Bonner JA
    J Clin Oncol; 2016 Apr; 34(12):1300-8. PubMed ID: 26712222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trial.
    Vermorken JB; Psyrri A; Mesía R; Peyrade F; Beier F; de Blas B; Celik I; Licitra L
    Ann Oncol; 2014 Apr; 25(4):801-807. PubMed ID: 24577117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current and future impact of human papillomavirus on treatment of squamous cell carcinoma of the head and neck.
    Psyrri A; Rampias T; Vermorken JB
    Ann Oncol; 2014 Nov; 25(11):2101-2115. PubMed ID: 25057165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of HPV status in recurrent/metastatic squamous cell carcinoma of the head and neck.
    Misiukiewicz K; Camille N; Gupta V; Bakst R; Teng M; Miles B; Genden E; Sikora A; Posner M
    Clin Adv Hematol Oncol; 2014 Dec; 12(12):812-9. PubMed ID: 25674839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systemic Treatment in HPV-Induced Recurrent or Metastatic HNSCC.
    Rieke DT; Keilholz U
    Recent Results Cancer Res; 2017; 206():149-160. PubMed ID: 27699536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HPV-positive head and neck tumours, a distinct clinical entity.
    Nevens D; Nuyts S
    B-ENT; 2015; 11(2):81-7. PubMed ID: 26563006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.
    Vermorken JB; Stöhlmacher-Williams J; Davidenko I; Licitra L; Winquist E; Villanueva C; Foa P; Rottey S; Skladowski K; Tahara M; Pai VR; Faivre S; Blajman CR; Forastiere AA; Stein BN; Oliner KS; Pan Z; Bach BA;
    Lancet Oncol; 2013 Jul; 14(8):697-710. PubMed ID: 23746666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive Factors for Outcome and Quality of Life in HPV-Positive and HPV-Negative HNSCC.
    Hess J
    Recent Results Cancer Res; 2017; 206():233-242. PubMed ID: 27699543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between human papilloma virus infection and expression of p16 and EGFR in head and neck squamous cell carcinoma and their prognostic significance].
    Ma L; Wang D; Wufuer A; Wu R; Zhang S; Wang R
    Zhonghua Zhong Liu Za Zhi; 2014 Jan; 36(1):23-8. PubMed ID: 24685082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The New Face of Head and Neck Cancer: The HPV Epidemic.
    Lewis A; Kang R; Levine A; Maghami E
    Oncology (Williston Park); 2015 Sep; 29(9):616-26. PubMed ID: 26384796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HPV-Related Head and Neck Squamous Cell Carcinomas.
    Marszałek A; Szylberg Ł
    Recent Results Cancer Res; 2017; 206():89-100. PubMed ID: 27699531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of multimodality treatment on overall survival for patients with metastatic or recurrent HPV-positive head and neck squamous cell carcinoma.
    Deeken JF; Newkirk K; Harter KW; Marshall MB; Banovac F; Johnson L; Wang H; Wang Y; Zhuang T; Jay AK; Berkowitz F; Esposito G; Kallakury B; Davidson B
    Head Neck; 2015 May; 37(5):630-5. PubMed ID: 24616038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus/p16 positive head and neck cancer in India: Prevalence, clinical impact, and influence of tobacco use.
    Murthy V; Swain M; Teni T; Pawar S; Kalkar P; Patil A; Chande A; Ghonge S; Laskar SG; Gupta T; Budrukkar A; Agrawal J
    Indian J Cancer; 2016; 53(3):387-393. PubMed ID: 28244466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
    Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
    Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytology in the era of HPV-related head and neck carcinoma.
    Roy-Chowdhuri S; Krishnamurthy S
    Semin Diagn Pathol; 2015 Jul; 32(4):250-7. PubMed ID: 25638437
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of tissue necrosis, hypoxia-related markers and correlation with HPV status in head and neck cancer patients treated with bio- or chemo-radiotherapy.
    Ou D; Garberis I; Adam J; Blanchard P; Nguyen F; Levy A; Casiraghi O; Gorphe P; Breuskin I; Janot F; Temam S; Scoazec JY; Deutsch E; Tao Y
    Radiother Oncol; 2018 Jan; 126(1):116-124. PubMed ID: 29079308
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic significance of the biomarker p16 in oropharyngeal squamous cell carcinoma.
    Oguejiofor KK; Hall JS; Mani N; Douglas C; Slevin NJ; Homer J; Hall G; West CM
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):630-8. PubMed ID: 23916365
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.